Literature DB >> 8880825

Respiratory depression following administration of low dose buprenorphine as postoperative analgesic after fentanyl balanced anaesthesia.

G Zanette1, G Manani, F Giusti, G Pittoni, C Ori.   

Abstract

Opioids are among the most ancient and widely used drugs in anaesthesiology. The pharmacology of opioid analgesics and their receptors is a complex and not fully understood matter; even more complex are the interactions between different classes of opioids at both molecular and clinical levels. We want to report here a clinical observation to emphasize the importance of the theoretical basis of anaesthesiology. This paper contains a clinical observation of respiratory depression following the administration of buprenorphine as postoperative analgesic after balanced anaesthesia with fentanyl. The observed case is interpreted in the light of the pharmacokinetics and pharmacodynamics of the different classes of opioid drugs (agonists, agonists-antagonists, antagonists) and of the interactions with their respective receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880825     DOI: 10.1046/j.1460-9592.1996.d01-1.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  3 in total

Review 1.  [Buprenorphine in children. A clinical and pharmacological review].

Authors:  E Michel; B Zernikow
Journal:  Schmerz       Date:  2006-02       Impact factor: 1.107

2.  [Practical pain control in pediatric oncology. Recommendations of the German Society of Pediatric Oncology and Hematology, the German Association for the Study of Pain, the German Society of Palliative Care, and the Vodafone Institute of Children's Pain Therapy and Palliative Care].

Authors:  B Zernikow; C Schiessl; C Wamsler; G Janssen; N Griessinger; R Fengler; F Nauck
Journal:  Schmerz       Date:  2006-02       Impact factor: 1.107

Review 3.  Pediatric palliative care: use of opioids for the management of pain.

Authors:  Boris Zernikow; Erik Michel; Finella Craig; Brian J Anderson
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.